Published in Nat Rev Rheumatol on August 04, 2015
Neuroinflammation in fibromyalgia and CRPS is multifactorial. Nat Rev Rheumatol (2016) 1.10
Effects of non-pharmacological interventions on inflammatory biomarker expression in patients with fibromyalgia: a systematic review. Arthritis Res Ther (2015) 0.77
Cost-utility and biological underpinnings of Mindfulness-Based Stress Reduction (MBSR) versus a psychoeducational programme (FibroQoL) for fibromyalgia: a 12-month randomised controlled trial (EUDAIMON study). BMC Complement Altern Med (2016) 0.75
Microvascular Response in Patients with Complex Regional Pain Syndrome as Measured by Laser Doppler Imaging. Microcirculation (2016) 0.75
Neuroinflammation in fibromyalgia and CRPS: top-down or bottom‑up? Nat Rev Rheumatol (2016) 0.75
The inflammasome in fibromyalgia and CRPS: a microglial hypothesis? Nat Rev Rheumatol (2015) 0.75
Fibromyalgia and microglial TNF-α: Translational research using human blood induced microglia-like cells. Sci Rep (2017) 0.75
Effects of Simvastatin Beyond Dyslipidemia: Exploring Its Antinociceptive Action in an Animal Model of Complex Regional Pain Syndrome-Type I. Front Pharmacol (2017) 0.75
Modulation of NMDA Receptor Activity in Fibromyalgia. Biomedicines (2017) 0.75
Central sensitization: implications for the diagnosis and treatment of pain. Pain (2010) 6.88
Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci (2009) 5.53
Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med (2007) 4.79
Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum (1981) 3.55
Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome. Pain (2006) 3.20
Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy? Ann Neurol (2009) 2.99
NK1 (substance P) receptor antagonists--why are they not analgesic in humans? Trends Pharmacol Sci (2000) 2.81
Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum (2007) 2.78
Small fibre pathology in patients with fibromyalgia syndrome. Brain (2013) 2.72
Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur J Neurosci (2008) 2.65
Fibromyalgia: a clinical review. JAMA (2014) 2.65
Hyperexcitable C nociceptors in fibromyalgia. Ann Neurol (2014) 2.34
Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci (2007) 2.19
Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain (2005) 2.00
Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol (2004) 1.99
Differential expression patterns of cytokines in complex regional pain syndrome. Pain (2007) 1.91
Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome. Pain (2011) 1.89
The important role of neuropeptides in complex regional pain syndrome. Neurology (2001) 1.88
Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients. Anesthesiology (2013) 1.86
Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med (2005) 1.86
Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol (2011) 1.83
Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum (2009) 1.76
Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. J Rheumatol (1999) 1.66
Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat Neurosci (2012) 1.66
The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol (2000) 1.60
The association between ACE inhibitors and the complex regional pain syndrome: Suggestions for a neuro-inflammatory pathogenesis of CRPS. Pain (2009) 1.60
Which nerve fibers mediate the axon reflex flare in human skin? Neuroreport (2000) 1.60
Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med (2007) 1.56
Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1. Mediators Inflamm (2006) 1.55
Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol (1998) 1.54
Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm (2002) 1.50
Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS). Neurosci Lett (2008) 1.50
Targeting cortical representations in the treatment of chronic pain: a review. Neurorehabil Neural Repair (2012) 1.47
The science of fibromyalgia. Mayo Clin Proc (2011) 1.47
Osteoprotegerin: a new biomarker for impaired bone metabolism in complex regional pain syndrome? Pain (2014) 1.45
Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum (1994) 1.45
Familial occurrence of complex regional pain syndrome. Can J Neurol Sci (2010) 1.43
Facilitated neurogenic inflammation in complex regional pain syndrome. Pain (2001) 1.43
Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia. Arthritis Rheum (2012) 1.40
Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain (2005) 1.38
Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord (2011) 1.30
Complex regional pain syndrome: a comprehensive and critical review. Autoimmun Rev (2013) 1.29
Patients with fibromyalgia display less functional connectivity in the brain's pain inhibitory network. Mol Pain (2012) 1.26
Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain (1988) 1.25
Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity. Nat Rev Neurosci (2013) 1.24
Inflammation in complex regional pain syndrome: a systematic review and meta-analysis. Neurology (2013) 1.20
Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder. J Pain (2009) 1.20
Complex regional pain syndrome in adults. Rheumatology (Oxford) (2011) 1.18
Glucocorticoid inhibition of vascular abnormalities in a tibia fracture rat model of complex regional pain syndrome type I. Pain (2006) 1.15
Conditioned pain modulation in populations with chronic pain: a systematic review and meta-analysis. J Pain (2012) 1.14
Is there a role for cytokine based therapies in fibromyalgia. Curr Pharm Des (2006) 1.12
The role of life stress in fibromyalgia. Curr Rheumatol Rep (2005) 1.11
A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Pain (2003) 1.11
Reflex sympathetic dystrophy of the hand: an excessive inflammatory response? Pain (1993) 1.11
Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease. Expert Opin Pharmacother (2009) 1.09
Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels. J Neuroimmunol (2011) 1.09
A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. J Rheumatol (1986) 1.08
Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression. Am J Psychiatry (2006) 1.07
A hypothesis for the cause of complex regional pain syndrome-type I (reflex sympathetic dystrophy): pain due to deep-tissue microvascular pathology. Pain Med (2010) 1.02
Intermediate stage complex regional pain syndrome type 1 is unrelated to proinflammatory cytokines. Mediators Inflamm (2005) 1.02
Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol (1999) 1.00
Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain (2007) 1.00
Mechanical hyperalgesia in complex regional pain syndrome: a role for TNF-alpha? Neurology (2005) 1.00
Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies. J Clin Rheumatol (2014) 0.99
Medical history and the onset of complex regional pain syndrome (CRPS). Pain (2008) 0.99
The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress (2007) 0.98
Interventions for treating pain and disability in adults with complex regional pain syndrome. Cochrane Database Syst Rev (2013) 0.98
Sympathetic nervous system influence on the innate immune response. Ann N Y Acad Sci (2006) 0.98
Regional sympathetic blockade in primary fibromyalgia. Pain (1988) 0.98
Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin Rheumatol (2010) 0.97
Memantine treatment of complex regional pain syndrome: a preliminary report of six cases. Clin J Pain (2007) 0.96
Neurologic signs and symptoms in fibromyalgia. Arthritis Rheum (2009) 0.95
Norepinephrine-evoked pain in fibromyalgia. A randomized pilot study [ISRCTN70707830]. BMC Musculoskelet Disord (2002) 0.95
Inflaming the brain: CRPS a model disease to understand neuroimmune interactions in chronic pain. J Neuroimmune Pharmacol (2012) 0.95
Diagnosis of fibromyalgia syndrome-a comparison of Association of the Medical Scientific Societies in Germany, survey, and American College of Rheumatology criteria. Clin J Pain (2010) 0.95
Fibromyalgia and related conditions. Mayo Clin Proc (2015) 0.93
Complex regional pain syndrome-significant progress in understanding. Pain (2015) 0.93
The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum (1997) 0.93
Small nerve fiber involvement in patients referred for fibromyalgia. Muscle Nerve (2014) 0.93
Increased venous alpha-adrenoceptor responsiveness in patients with reflex sympathetic dystrophy. Ann Intern Med (1993) 0.93
Fibromyalgia and cytokines. Immunol Lett (2014) 0.92
Increased neurogenic inflammation in fibrositis syndrome. J Rheumatol (1987) 0.92
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol (2014) 0.92
Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr Pain Headache Rep (2007) 0.91
History of fibromyalgia: past to present. Curr Pain Headache Rep (2004) 0.91
Activation of cutaneous immune responses in complex regional pain syndrome. J Pain (2014) 0.90
A chronic fatigue syndrome model demonstrates mechanical allodynia and muscular hyperalgesia via spinal microglial activation. Glia (2014) 0.90
Traumatic experiences, major life stressors, and self-reporting a physician-given fibromyalgia diagnosis. Psychiatry Res (2010) 0.90
A Lecture on Lumbago: Its Lessons and Analogues: Delivered at the National Hospital for the Paralysed and Epileptic. Br Med J (1904) 0.90
Dermal IgG deposits and increase of mast cells in patients with fibromyalgia--relevant findings or epiphenomena? Scand J Rheumatol (1997) 0.90
Primary somatosensory cortex function in complex regional pain syndrome: a systematic review and meta-analysis. J Pain (2013) 0.89
Central amplification and fibromyalgia: disorder of pain processing. J Neurosci Res (2011) 0.89
Involvement of the sympathetic nervous system in complex regional pain syndrome. Int J Low Extrem Wounds (2004) 0.88
Immunoglobulin g for the treatment of chronic pain: report of an expert workshop. Pain Med (2014) 0.88
Inflammation in CRPS: role of the sympathetic supply. Auton Neurosci (2013) 0.87
Effect of immunomodulating medications in complex regional pain syndrome: a systematic review. Clin J Pain (2012) 0.86
Modulation of pain in fibromyalgia (fibrositis syndrome): cerebrospinal fluid (CSF) investigation of pain related neuropeptides with special reference to calcitonin gene related peptide (CGRP). J Rheumatol Suppl (1989) 0.86
Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: a controlled study. J Neurol Sci (2014) 0.86
Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndrome. Cochrane Database Syst Rev (2010) 0.85
A controlled and blinded study of immunoreactant deposition at the dermal-epidermal junction of patients with primary fibrositis syndrome. J Rheumatol (1986) 0.85